A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study.
OBJECTIVE
The authors have developed a mixture of ethylene vinyl alcohol copolymer (EVAL) and iopamidol, which is dissolved in ethanol, as an alternative solvent to provide a safe means of embolizing arteriovenous malformations (AVMs).


METHODS
A two-stage delivery technique is required to prevent premature precipitation in the catheter when using this material: the catheter is first infused with 30% ethanol and this is followed by the delivery of the EVAL-ethanol mixture. Acute angiographic changes were analyzed after superselective delivery of dimethyl sulfoxide (DMSO) and 30% ethanol into the renal artery of rabbits. Histological changes following the embolization of the renal artery achieved using the EVAL-ethanol mixture were recorded at 1 hour and at 2 and 16 weeks after the procedure. Although DMSO always produced severe, rapidly progressive vasospasm in the renal artery during a 1- to 60-minute postinfusion, 30% ethanol did not. Microscopically, the lumens of embolized vessels examined 1 hour after embolization with EVAL-ethanol appeared to be filled with EVAL sponges, leaving almost no open spaces. The space between the EVAL sponges and the inner surface of the vessels was filled with fresh thrombus. In the vessel walls of specimens examined 2 weeks after embolization there was no or a slight inflammatory reaction. Scattered in the EVAL sponges were almost equal numbers of neutrophilic granulocytes and mononuclear cells, indicative of a mild inflammatory response. In specimens examined 16 weeks postembolization, the changes noted at 2 weeks were intensified. There was no definite histopathological evidence of mural hemorrhage, perivascular extravasation of the mixture, or perivascular hemorrhage in any specimen that was examined.


CONCLUSIONS
Although the degree of permanence of this embolization material is yet unknown, the mixture was easy to handle, and appeared safe and effective for AVM embolization. Its nonadhesive characteristic and its ability to be infused by repeated injections make it an attractive alternative to currently available materials. The good results obtained in this study led us to undertake a clinical trial, the results of which are contained in a companion article in this issue of the Journal of Neurosurgery.
Hamada
Jun-ichiro
J
Department of Neurosurgery, Kumamoto University School of Medicine, Japan. j-hamada@fc.kuh.kumamoto-u.ac.jp
Kai
Yutaka
Y
Morioka
Motohiro
M
Kazekawa
Kiyoshi
K
Ishimaru
Yasuji
Y
Iwata
Hiroo
H
Ushio
Yukitaka
Y
D000818:Animals; D004621:Embolization, Therapeutic / Q000379:methods*; D000431:Ethanol; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy*; D008297:Male; D011145:Polyvinyls; D011817:Rabbits; D012077:Renal Artery / Q000187:drug effects / Q000473:pathology; D012997:Solvents
D011145:Polyvinyls; D012997:Solvents; C020320:ethylene-vinyl alcohol copolymer; D000431:Ethanol